Novelix Pharmaceuticals Ltd said in an October 2, 2026 BSE filing that shareholders approved the appointment of Gnana Prakash Gattu as whole-time director at the company’s 32nd Annual General Meeting held on September 30, 2026. The appointment is for five years, effective August 29, 2026.

The disclosure sets out both the effective date of the appointment and the subsequent shareholder approval. August 29 is the date from which the appointment takes effect, while September 30 is the date on which members approved it at the AGM. The company communicated that approval to BSE through its October 2 letter.

Novelix Pharmaceuticals, formerly known as Trimurthi Limited, submitted the director appointment disclosure under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The company is identified on BSE by scrip code 536565 and scrip ID NOVELIX.

Gattu’s experience and promoter affiliation

The filing identifies the appointee as Gnana Prakash Gattu, DIN 00517921. Its accompanying profile describes him as a graduate of IIT-Chennai with more than 25 years of experience in management and information technology.

The annexure also provides the following details about his relationship with the company and eligibility to hold office:

  • Gattu belongs to the company’s promoters and promoter group.
  • He is not related to any of the company’s directors or key managerial personnel.
  • He is not debarred from holding the office of director by any SEBI order or any other such authority.

The relationship disclosure therefore records his promoter-group affiliation separately from the statement that he has no relationship with the directors or key managerial personnel.

Details submitted to BSE

The filing was signed by Venkateshwarlu Pulluru, whole-time director, whose DIN is 02076871. The company requested BSE to take the information on record and disseminate it through the exchange’s website.

Novelix included an annexure covering the reason for the director change, the effective appointment date, Gattu’s professional profile, relationship disclosures and eligibility declaration. The five-year tenure is stated in the main letter accompanying those details.